IPA
ImmunoPrecise Antibodies Ltd. (IPA)
$52
About ImmunoPrecise Antibodies Ltd. (IPA)
ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.
Details
Daily high
$0.55
Daily low
$0.51
Price at open
$0.52
52 Week High
$2.60
52 Week Low
$0.32
Market cap
13.0M
Dividend yield
0.00%
Volume
2,502
Avg. volume
375,256
P/E ratio
-.69
ImmunoPrecise Antibodies Ltd. News
Details
Daily high
$0.55
Daily low
$0.51
Price at open
$0.52
52 Week High
$2.60
52 Week Low
$0.32
Market cap
13.0M
Dividend yield
0.00%
Volume
2,502
Avg. volume
375,256
P/E ratio
-.69